Investment Summary |
|
|---|---|
| Date | 2022-09-14 |
| Target | Capstan |
| Sector | Life Science |
| Investor(s) | Polaris Partners |
| Deal Type | Venture |
SEARCH BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1996 |
| PE ASSETS | 5.0B USD |
| Size | Large |
| Type | Sector Agnostic |
Polaris Partners is primarily a seed, first round, and early stage venture capital investor in information technology and life science businesses. However, Polaris also focuses on private equity investments in established companies. In this area, Polaris targets high growth middle market companies in industries including technology, healthcare, digital media, consumer products and services, and business services. The firm's investments include minority growth equity investments, recapitalizations with liquidity, and leveraged buyouts. Polaris Partners was formed in 1996 and has offices in Seattle, Washington and Waltham, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 87 of 87 |
| Sector: Life Science M&A | 39 of 39 |
| Type: Venture M&A Deals | 57 of 57 |
| State: California M&A | 14 of 14 |
| Country: United States M&A | 78 of 78 |
| Year: 2022 M&A | 6 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-07-25 |
Amplifire
Boulder, Colorado, United States Amplifire is a provider of adaptive learning and assessment software to higher education institutions, publishers, test-preparation providers, certification associations and healthcare providers. Amplifire, is a fully hosted SaaS application that leverages scientific breakthroughs from the fields of cognitive psychology, neurobiology and game studies to deliver superior learning outcomes. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-01-30 |
Tectonic Therapeutic /old/
Watertown, Massachusetts, United States Tectonic Therapeutic aims to transform the discovery of novel drugs addressing targets in the GPCR family. Tectonic Therapeutic was founded in 2019 and is based in Watertown, Massachusetts. |
Sell | - |
